abstract |
The phenomenon of multidrug resistance (MDR) in human cancers is one of the major causes of failure of chemotherapy. The fungal secondary metabolite tryprostatin A (TPS-A), a diketopiperazine, has been shown to overcome multi-drug resistance, and to inhibit lipid transport, whilst no cytotoxicity of the compound itself could be observed. |